Heart, Lung and Circulation
Volume 17, Issue 3 , Pages 211-214 , June 2008

Transoesophageal Echocardiography And Cardioversion: Feasibility of A Combined Approach in Clinical Practice

  • Liza Thomas, FRACP

      Affiliations

    • Department of Cardiology, Westmead Hospital, Darcy Road, Sydney, NSW 2145, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 98456795; fax: +61 2 98458323.
    • ,
  • Michael Veltman, FRACP

      Affiliations

    • Department of Anaesthesia, Westmead Hospital, Sydney, NSW 2145, Australia
    • ,
  • Kate Levett, BEd (HME) Hons

      Affiliations

    • Department of Cardiology, Westmead Hospital, Darcy Road, Sydney, NSW 2145, Australia
    • ,
  • Michelle Hoy, BSci(Biomedical)

      Affiliations

    • Department of Cardiology, Westmead Hospital, Darcy Road, Sydney, NSW 2145, Australia
    • ,
  • David L. Ross, FRACP

      Affiliations

    • Department of Cardiology, Westmead Hospital, Darcy Road, Sydney, NSW 2145, Australia

Received 5 March 2007 ,Revised 2 August 2007 ,Accepted 29 October 2007.

References 

  1. Prystowsky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJ, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996;93:1262–1277
  2. Catherwood E, Fitzpatrick WD, Greenberg ML, Holzberger PT, Malenka DJ, Gerling BR, et al. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med. 1999;130:625–636
  3. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25:452–459
  4. Daniel Werner GMD, Erbel Raimund MD, Kasper Wolfgang MD, Visser Cees AMD, Engberding Rolf MD, Sutherland George RMD, et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation. 1991;83:817–821
  5. Seto TB, Taira DA, Tsevat J, Manning WJ. Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation. J Am Coll Cardiol. 1997;29:122–130
  6. Murray RD, Deitcher SR, Shah A, Jasper SE, Bashir M, Grimm RA, et al. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. J Am Soc Echocardiogr. 2001;14:200–208
  7. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for “atrial stunning” as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994;23:307–316
  8. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993;22:1359–1366
  9. Carlsson J, Tebbe U, Rox J, Harmjanz D, Haerten K, Neuhaus KL, et al. Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte. Am J Cardiol. 1996;78:1380–1384
  10. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol. 2001;37:691–704
  11. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001;344:1411–1420

PII: S1443-9506(07)01075-X

doi: 10.1016/j.hlc.2007.10.010

Heart, Lung and Circulation
Volume 17, Issue 3 , Pages 211-214 , June 2008

Article Tools